The frequency of worsening renal function during hospitalization was similar in the nesiritide and placebo group ( 14.1 % and 12.8 % , respectively ; odds ratio with nesiritide 1.12 ; confidence interval , 0.95-1 .32 ; P = 0.19 ) and was not associated with death alone and death or rehospitalization at 30 days .